{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:06:08Z","timestamp":1792476368693,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["1-RSC-2017-368-I-X"],"award-info":[{"award-number":["1-RSC-2017-368-I-X"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["1-IND-2019-717-I-X"],"award-info":[{"award-number":["1-IND-2019-717-I-X"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["1-SRA-2019-722-I-X"],"award-info":[{"award-number":["1-SRA-2019-722-I-X"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["1-RSC-2017-517-I-X"],"award-info":[{"award-number":["1-RSC-2017-517-I-X"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["5-ECR-2017-388-A-N"],"award-info":[{"award-number":["5-ECR-2017-388-A-N"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["1-SRA-2019-720-I-X"],"award-info":[{"award-number":["1-SRA-2019-720-I-X"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["1-RSC-2017-526-I-X"],"award-info":[{"award-number":["1-RSC-2017-526-I-X"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","award":["1-RSC-2018-555-I-X"],"award-info":[{"award-number":["1-RSC-2018-555-I-X"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["292538"],"award-info":[{"award-number":["292538"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","award":["IRC15-0067"],"award-info":[{"award-number":["IRC15-0067"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Development of islet autoimmunity precedes the onset of type 1 diabetes in children, however, the presence of autoantibodies does not necessarily lead to manifest disease and the onset of clinical symptoms is hard to predict. Here we show, by longitudinal sampling of islet autoantibodies (IAb) to insulin, glutamic acid decarboxylase and islet antigen-2 that disease progression follows distinct trajectories. Of the combined Type 1 Data Intelligence cohort of 24662 participants, 2172 individuals fulfill the criteria of two or more follow-up visits and IAb positivity at least once, with 652 progressing to type 1 diabetes during the 15 years course of the study. Our Continuous-Time Hidden Markov Models, that are developed to discover and visualize latent states based on the collected data and clinical characteristics of the patients, show that the health state of participants progresses from 11 distinct latent states as per three trajectories (TR1, TR2 and TR3), with associated 5-year cumulative diabetes-free survival of 40% (95% confidence interval [CI], 35% to 47%), 62% (95% CI, 57% to 67%), and 88% (95% CI, 85% to 91%), respectively (p\u2009&lt;\u20090.0001). Age, sex, and HLA-DR status further refine the progression rates within trajectories, enabling clinically useful prediction of disease onset.<\/jats:p>","DOI":"10.1038\/s41467-022-28909-1","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T11:03:30Z","timestamp":1647860610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9391-6274","authenticated-orcid":false,"given":"Bum Chul","family":"Kwon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8605-5712","authenticated-orcid":false,"given":"Vibha","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6720-2684","authenticated-orcid":false,"given":"Peter","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0134-4177","authenticated-orcid":false,"given":"Jessica L.","family":"Dunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-0475","authenticated-orcid":false,"given":"William","family":"Hagopian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7753-886X","authenticated-orcid":false,"given":"Jianying","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3621-9613","authenticated-orcid":false,"given":"Eileen","family":"Koski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1735-0499","authenticated-orcid":false,"given":"\u00c5ke","family":"Lernmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6394-7689","authenticated-orcid":false,"given":"Markus","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-070X","authenticated-orcid":false,"given":"Kenney","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2228-334X","authenticated-orcid":false,"given":"Jorma","family":"Toppari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6557-270X","authenticated-orcid":false,"given":"Riitta","family":"Veijola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte I.","family":"Frohnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the T1DI Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,21]]},"reference":[{"key":"28909_CR1","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.2337\/db13-0300","volume":"62","author":"J Ilonen","year":"2013","unstructured":"Ilonen, J. et al. Patterns of \u03b2-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 62, 3636\u20133640 (2013).","journal-title":"Diabetes"},{"key":"28909_CR2","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","volume":"25","author":"K Vehik","year":"2019","unstructured":"Vehik, K. et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat. Med. 25, 1865\u20131872 (2019).","journal-title":"Nat. Med."},{"key":"28909_CR3","doi-asserted-by":"publisher","unstructured":"Vehik, K. et al. Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY study. Diabetes Carehttps:\/\/doi.org\/10.2337\/dc19-2547 (2020).","DOI":"10.2337\/dc19-2547"},{"key":"28909_CR4","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jaut.2017.09.005","volume":"86","author":"KF Lynch","year":"2018","unstructured":"Lynch, K. F. et al. Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident beta-cell autoantibodies. J. Autoimmun. 86, 93\u2013103 (2018).","journal-title":"J. Autoimmun."},{"key":"28909_CR5","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","volume":"58","author":"JP Krischer","year":"2015","unstructured":"Krischer, J. P. et al. The 6\u2009year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 58, 980\u2013987 (2015).","journal-title":"Diabetologia"},{"key":"28909_CR6","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.2337\/dc17-0238","volume":"40","author":"JP Krischer","year":"2017","unstructured":"Krischer, J. P. et al. Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6\u2009years of age: the TEDDY study. Diabetes Care 40, 1194\u20131202 (2017).","journal-title":"Diabetes Care"},{"key":"28909_CR7","doi-asserted-by":"publisher","first-page":"4521","DOI":"10.1210\/jc.2019-00421","volume":"104","author":"W Bauer","year":"2019","unstructured":"Bauer, W. et al. Age at seroconversion, HLA genotype, and specificity of autoantibodies in progression of islet autoimmunity in childhood. J. Clin. Endocrinol. Metab. 104, 4521\u20134530 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"28909_CR8","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1007\/s00125-016-4050-0","volume":"59","author":"D Endesfelder","year":"2016","unstructured":"Endesfelder, D. et al. A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children. Diabetologia 59, 2172\u20132180 (2016).","journal-title":"Diabetologia"},{"key":"28909_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.2337\/db18-0594","volume":"68","author":"D Endesfelder","year":"2019","unstructured":"Endesfelder, D. et al. Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children. Diabetes 68, 119\u2013130 (2019).","journal-title":"Diabetes"},{"key":"28909_CR10","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler, A. G. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309, 2473\u20132479 (2013).","journal-title":"JAMA"},{"key":"28909_CR11","doi-asserted-by":"crossref","unstructured":"Anand, V. et al. Islet autoimmunity and HLA markers of presymptomatic and clinical type 1 diabetes: joint analyses of prospective cohort studies in Finland, Germany, Sweden, and The United States. Diabetes Care 44, 2269\u20132276 (2021).","DOI":"10.2337\/dc20-1836"},{"key":"28909_CR12","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel, R. A. et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38, 1964\u20131974 (2015).","journal-title":"Diabetes Care"},{"key":"28909_CR13","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.2337\/dc16-0181","volume":"39","author":"K Vehik","year":"2016","unstructured":"Vehik, K. et al. Reversion of \u03b2-cell autoimmunity changes risk of type 1 diabetes: TEDDY study. Diabetes Care 39, 1535\u20131542 (2016).","journal-title":"Diabetes Care"},{"key":"28909_CR14","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1111\/pedi.12697","volume":"19","author":"M Turtinen","year":"2018","unstructured":"Turtinen, M., H\u00e4rk\u00f6nen, T., Parkkola, A., Ilonen, J. & Knip, M. Sex as a determinant of type 1 diabetes at diagnosis. Pediatr. Diabetes 19, 1221\u20131228 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"28909_CR15","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1001\/jama.2019.21565","volume":"323","author":"A-G Ziegler","year":"2020","unstructured":"Ziegler, A.-G. et al. Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany. JAMA 323, 339\u2013351 (2020).","journal-title":"JAMA"},{"key":"28909_CR16","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.2337\/dc19-2003","volume":"43","author":"RB McQueen","year":"2020","unstructured":"McQueen, R. B. et al. Cost and cost-effectiveness of large-scale screening for type 1 diabetes in colorado. Diabetes Care 43, 1496\u20131503 (2020).","journal-title":"Diabetes Care"},{"key":"28909_CR17","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2017.17070","volume":"318","author":"Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group.","year":"2017","unstructured":"Writing Committee for the Type 1 Diabetes TrialNet Oral Insulin Study Group. et al. Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes: a randomized clinical trial. JAMA 318, 1891\u20131902 (2017).","journal-title":"JAMA"},{"key":"28909_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1056\/NEJMoa1902226","volume":"381","author":"KC Herold","year":"2019","unstructured":"Herold, K. C. et al. An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes. N. Engl. J. Med. 381, 603\u2013613 (2019).","journal-title":"N. Engl. J. Med."},{"key":"28909_CR19","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.2337\/db14-0095","volume":"63","author":"CA Beam","year":"2014","unstructured":"Beam, C. A., Gitelman, S. E. & Palmer, J. P., Group, the T. 1 D. T. S. Recommendations for the definition of clinical responder in insulin preservation studies. Diabetes 63, 3120\u20133127 (2014).","journal-title":"Diabetes"},{"key":"28909_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s001250050514","volume":"39","author":"M Rewers","year":"1996","unstructured":"Rewers, M. et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study in the young (DAISY). Diabetologia 39, 807\u2013812 (1996).","journal-title":"Diabetologia"},{"key":"28909_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/pedi.12325","volume":"17","author":"HE Larsson","year":"2016","unstructured":"Larsson, H. E. A Swedish approach to the prevention of type 1 diabetes. Pediatr. Diabetes 17, 73\u201377 (2016).","journal-title":"Pediatr. Diabetes"},{"key":"28909_CR22","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.2337\/db08-1305","volume":"58","author":"HTA Siljander","year":"2009","unstructured":"Siljander, H. T. A. et al. Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 58, 2835\u20132842 (2009).","journal-title":"Diabetes"},{"key":"28909_CR23","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1196\/annals.1288.067","volume":"1005","author":"E Wion","year":"2003","unstructured":"Wion, E. et al. Population-wide infant screening for HLA-based type 1 diabetes risk via dried blood spots from the public health infrastructure. Ann. N. Y. Acad. Sci. 1005, 400\u2013403 (2003).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"28909_CR24","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2337\/diabetes.48.3.460","volume":"48","author":"AG Ziegler","year":"1999","unstructured":"Ziegler, A. G., Hummel, M., Schenker, M. & Bonifacio, E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes 48, 460\u2013468 (1999).","journal-title":"Diabetes"},{"key":"28909_CR25","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.2337\/dc20-S002","volume":"43","author":"American Diabetes Association.","year":"2020","unstructured":"American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care 43, S14\u2013S31 (2020).","journal-title":"Diabetes Care"},{"key":"28909_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/jamiaopen\/ooy060","volume":"2","author":"Z Sun","year":"2019","unstructured":"Sun, Z. et al. A probabilistic disease progression modeling approach and its application to integrated Huntington\u2019s disease observational data. JAMIA Open 2, 123\u2013130 (2019).","journal-title":"JAMIA Open"},{"key":"28909_CR27","doi-asserted-by":"publisher","first-page":"4581","DOI":"10.1002\/sim.5861","volume":"32","author":"JM Lange","year":"2013","unstructured":"Lange, J. M. & Minin, V. N. Fitting and interpreting continuous-time latent Markov models for panel data. Stat. Med. 32, 4581\u20134595 (2013).","journal-title":"Stat. Med."},{"key":"28909_CR28","first-page":"668","volume":"2020","author":"BC Kwon","year":"2020","unstructured":"Kwon, B. C. et al. Modeling disease progression trajectories from longitudinal observational data. AMIA Annu. Symp. Proc. 2020, 668\u2013676 (2020).","journal-title":"AMIA Annu. Symp. Proc."},{"key":"28909_CR29","doi-asserted-by":"publisher","unstructured":"Kwon, B. C. et al. DPVis: visual analytics with hidden Markov models for disease progression pathways. IEEE Trans. Vis. Comput. Graph.https:\/\/doi.org\/10.1109\/TVCG.2020.2985689 (2020).","DOI":"10.1109\/TVCG.2020.2985689"},{"key":"28909_CR30","unstructured":"Claeskens, G. & Hjort, N. L. Model Selection and Model Averaging (Cambridge University Press, 2008)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28909-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28909-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28909-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T16:43:25Z","timestamp":1669308205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-28909-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,21]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["28909"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-28909-1","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,21]]},"assertion":[{"value":"23 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.C.K., V.A., J.H., E.K., K.N. are currently employees of IBM Research. J.L.D. is currently an employee of Janssen Research & Development, LLC, however, the work was done while she was at JDRF. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1514"}}